Evidence map›Paper›PMID 37046673›Full record

ArticleCancers2023

Radiomics Analysis of

Jang Yoo, Jaeho Lee, Miju Cheon, Hojoong Kim, Yong Soo Choi, Hongryull Pyo, Myung-Ju Ahn, Joon Young Choi

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Radiomics based onFrontiers in oncology · 2024
    Article
  6. Article
  7. The value ofTzu chi medical journal
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jang YooDepartment of Nuclear Medicine, Veterans Health Service Medical Center, Seoul 05368, Republic of Korea.ORCID 0000-0003-4664-4904
Jaeho LeeDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.ORCID 0009-0005-0904-459X
Miju CheonDepartment of Nuclear Medicine, Veterans Health Service Medical Center, Seoul 05368, Republic of Korea.ORCID 0000-0001-7469-7769
Hojoong KimDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
Yong Soo ChoiDepartment of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
Hongryull PyoDepartment of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
Myung-Ju AhnDivision of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
Joon Young ChoiDepartment of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.ORCID 0000-0003-1060-0096
Samsung Medical Center · KRVeterans Health Service Medical Center · KRSeoul National University · KR

Funding

National Research Foundation of Korea (NRF) by Korean government (Ministry of Science and ICT) NRF-2020M2D9A1094072VHS Medical Center Research Grant VHSMC 23026
6 · The paper itself

Abstract

We investigated the prognostic significance of radiomic features from

Indexed as

18F-FDG PET/CTdecision curve analysisLASSO scorenon-small cell lung canceroverall survivalradiomics

Identifiers

PMID37046673
PMCPMC10093358
OpenAlexW4361217699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.